Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes

An in vitro carcinogenesis model of human skin keratinocytes has been developed based on the spontaneously immortalized keratinocyte cell line HaCaT. Immortalization, the initial stage in human carcinogenesis in vitro, was induced by ultraviolet‐type mutations in the p53 gene followed by further genetic alterations leading to the loss of senescence genes, in particular on chromosome 3p. Despite multiple genetic changes, the HaCaT cell line sustained its genomic balance up to high passage levels and maintained a non‐tumorigenic phenotype. Tumorigenic transformation was induced by ras oncogene transfection but also by culture stress and elevated temperature, resulting in benign and malignant tumorigenic clones. Malignant conversion was associated with the loss of a copy of chromosome 15, leading to a decrease in thrombospondin‐1 (TSP‐1) expression. Heat‐induced malignant conversion was associated with a gain of material on chromosome 11, including the cyclin D1 gene. The microenvironment plays a major role in tumorigenic transformation and the control of malignant cells. Overexpression of platelet‐derived growth factor in HaCaT cells caused mesenchyme activation and formation of benign tumors. Halting tumor angiogenesis completely prevented invasion of malignant cells and induced a benign tumor phenotype. Transfer of a normal chromosome 15 or TSP‐1 transfection into a skin carcinoma line resulted in tumor suppression due to TSP‐1–blocked tumor vascularization. Because of the reduced TSP‐1 expression, blood vessels infiltrated the tumor, and it expanded. Progression to more aggressive tumor phenotypes required the in vivo environment and was caused by selection of a subpopulation and further genetic modifications. The improved autonomous growth of these cells was associated with new expression of granulocyte colony‐stimulating factor and granulocyte‐macrophage colony‐stimulating factor, which acted in an autocrine manner to stimulate proliferation and migration. With this in vitro skin carcinogenesis model we were able to demonstrate multiple stages in the transformation process that were associated with different genetic and phenotypic characteristics. In addition, we documented that modulation of the tumor stroma plays an important and decisive role in tumor development and progression. From this we hypothesize that the growth restraints of the microenvironment are increasingly lost with advancing stages of carcinogenesis but can be restored by modulation of the tumor stroma. Mol. Carcinog. 23:144–158, 1998. © 1998 Wiley‐Liss, Inc.

[1]  N. Weidner Intratumor microvessel density as a prognostic factor in cancer. , 1995, The American journal of pathology.

[2]  I. Fidler,et al.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. , 1990, Cancer research.

[3]  T. Jacks,et al.  Sunburn and p53 in the onset of skin cancer , 1994, Nature.

[4]  L. Hayflick Mortality and immortality at the cellular level. A review. , 1997, Biochemistry. Biokhimiia.

[5]  R. Reddel,et al.  SV40-induced immortalization of human cells. , 1994, Critical reviews in oncogenesis.

[6]  M. Skobe,et al.  Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Kerbel,et al.  Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis. , 1996, European journal of cancer.

[8]  J. R. Smith,et al.  Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. English,et al.  UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. Heldin,et al.  Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Kerbel,et al.  Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogene expression , 1995, The Journal of cell biology.

[12]  N. Fusenig,et al.  Integrin and basement membrane normalization in mouse grafts of human keratinocytes--implications for epidermal homeostasis. , 1997, Differentiation; research in biological diversity.

[13]  Y. Ueyama,et al.  Failure of genotoxic carcinogens to produce tumors in human skin xenografts transplanted to SCID mice. , 1995, Carcinogenesis.

[14]  N. Fusenig,et al.  Carcinogenesis Studies of Human Cells: Reliable In Vitro Models , 1994 .

[15]  A. Knudson,et al.  Antioncogenes and human cancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Y. Wang,et al.  Regulation of the cell cycle machinery by oncogenic ras. , 1996, Oncogene.

[17]  J. Rhim,et al.  Neoplastic Transformation in Human Cell Culture , 1991, Experimental Biology and Medicine.

[18]  N. Fusenig,et al.  Density-dependent modulation of synthesis of keratins 1 and 10 in the human keratinocyte line HACAT and in ras-transfected tumorigenic clones. , 1989, Differentiation; research in biological diversity.

[19]  K. Mihara,et al.  Immortalization of human cells and its mechanisms. , 1996, Critical reviews in oncogenesis.

[20]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[21]  N. Fusenig,et al.  Altered Regulation of Growth and Differentiation at Different Stages of Transformation of Human Skin Keratinocytes , 1991 .

[22]  R. Metcalf,et al.  p53 mutations in human immortalized epithelial cell lines. , 1993, Carcinogenesis.

[23]  J. R. Smith,et al.  Genetic analysis of indefinite division in human cells: identification of four complementation groups. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Prendergast,et al.  Pathways of Ras function: connections to the actin cytoskeleton. , 1993, Advances in cancer research.

[25]  D. Lane,et al.  p53, guardian of the genome , 1992, Nature.

[26]  J. Simon,et al.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Boukamp,et al.  Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Herlyn,et al.  Carcinogenesis in human skin grafted to SCID mice. , 1996, Cancer research.

[29]  B. Marczynska,et al.  Role of elevated temperature in malignant transformation of mammalian cells in vztro , 1980, International journal of cancer.

[30]  Georg Bauer,et al.  Stimulatory role of transforming growth factors in multistage skin carcinogenesis: Possible explanation for the tumor‐inducing effect of wounding in initiated nmri mouse skin , 1989, International journal of cancer.

[31]  P. Gallimore,et al.  Malignant progression of an SV40-transformed human epidermal keratinocyte cell line. , 1987, British Journal of Cancer.

[32]  N. Fusenig,et al.  Functional evidence for tumor‐suppressor activity on chromosome 15 in human skin carcinoma cells and thrombospondin‐1 as the potential suppressor , 1997, Journal of cellular physiology.

[33]  S. Werner,et al.  Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. , 1994, Oncogene.

[34]  N. Fusenig,et al.  Step-wise progression in human skin carcinogenesis in vitro involves mutational inactivation of p53, rasH oncogene activation and additional chromosome loss. , 1995, Oncogene.

[35]  N. Fusenig,et al.  Phenotypic and cytogenetic characteristics of different stages during spontaneous transformation of mouse keratinocytes in vitro. , 1985, Carcinogenesis; a comprehensive survey.

[36]  T. Cremer,et al.  Sustained nontumorigenic phenotype correlates with a largely stable chromosome content during long‐term culture of the human keratinocyte line HaCaT , 1997, Genes, chromosomes & cancer.

[37]  P. Cerutti,et al.  c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. , 1990, Cancer research.

[38]  C. Paraskeva,et al.  Colorectal carcinogenesis: sequential steps in the in vitro immortalization and transformation of human colonic epithelial cells (review). , 1990, Anticancer research.

[39]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[40]  N. Fusenig,et al.  Environmental modulation of the expression of differentiation and malignancy in six human squamous cell carcinoma cell lines. , 1985, Cancer research.

[41]  J. Barrett,et al.  Genetic and cellular basis of multistep carcinogenesis. , 1990, Pharmacology & therapeutics.

[42]  Mihaela Skobe,et al.  Halting angiogenesis suppresses carcinoma cell invasion , 1997, Nature Medicine.

[43]  J. S. Kang,et al.  Ras induces anchorage-independent growth by subverting multiple adhesion-regulated cell cycle events , 1996, Molecular and cellular biology.

[44]  D. Marmé,et al.  Both v-Ha-Ras and v-Raf Stimulate Expression of the Vascular Endothelial Growth Factor in NIH 3T3 Cells (*) , 1995, The Journal of Biological Chemistry.

[45]  E. Musgrove,et al.  Involvement of RB-1, p53, p16INK4 and telomerase in immortalisation of human cells. , 1995, Oncogene.

[46]  M. Herlyn,et al.  Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[47]  N. Fusenig,et al.  Epidermal morphogenesis and keratin expression in c-Ha-ras-transfected tumorigenic clones of the human HaCaT cell line. , 1991, Cancer research.

[48]  T. Tong,et al.  Cancer statistics, 1994 , 1994, CA: a cancer journal for clinicians.

[49]  J. Hornung,et al.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line , 1988, The Journal of cell biology.

[50]  N. Fusenig,et al.  Progressive abrogation of TGF‐β‐1 and EGF growth control is associated with tumour progression in ras‐transfected human keratinocytes , 1992, International journal of cancer.

[51]  F. Sarkar,et al.  Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. , 1995, The Journal of clinical investigation.

[52]  S. Yuspa The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis--thirty-third G. H. A. Clowes Memorial Award Lecture. , 1994, Cancer research.

[53]  R. Kerbel,et al.  Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. , 1995, Cancer research.

[54]  N. Fusenig,et al.  Epidermal differentiation and basement membrane formation by HaCaT cells in surface transplants. , 1998, European journal of cell biology.

[55]  P. Cerutti,et al.  In vitro transformation of human skin epithelial cells: Role of RAS oncogene in malignant progression. , 1990, Toxicology in vitro : an international journal published in association with BIBRA.

[56]  M. Oshimura,et al.  Induction of cellular senescence in immortalized cells by human chromosome 1. , 1990, Science.

[57]  J. Jenkins,et al.  Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53 , 1984, Nature.

[58]  N. Fusenig,et al.  Differential modulation of epidermal keratinization in immortalized (HaCaT) and tumorigenic human skin keratinocytes (HaCaT-ras) by retinoic acid and extracellular Ca2+. , 1993, Differentiation; research in biological diversity.